UBS Juggles Debt Tender, Washington Scrutiny, and Bern's Capital Question
Published on 09/03/2026 at 18:50 | Editorial boerse-global.deThe machinery at UBS is running on multiple tracks at once. Even as the bank pushes ahead with a fresh round of debt buybacks aimed at streamlining its capital structure, it finds itself squeezed between a US Senate inquiry into decades-old Credit Suisse accounts and a Swiss regulatory debate that could redraw its capital requirements.
The latest tender offer covers nine outstanding Credit Suisse bonds with a maximum volume of roughly $6 billion. The offer window remains open until September 10, and the instruments in scope carry coupons ranging from 0.50 percent to 4.375 percent. Their combined face value spans three currencies: £1.2 billion, $9.54 billion, and €2.05 billion. The rationale is straightforward — retiring higher-cost paper trims interest expenses and tightens the group's funding profile.
Washington Turns Up the Heat
That financial engineering is unfolding against a political backdrop that shows no signs of cooling. Senate Judiciary Committee Chairman Charles Grassley has fired off a fresh letter dated July 17 demanding answers on Nazi-era accounts held at the former Credit Suisse, adding 62 new questions to an inquiry that has simmered for years. The correspondence has since been made public.
UBS points to the $1.25 billion settlement Swiss banks reached in 1998 to resolve similar allegations, and notes its own internal review is scheduled to conclude by the end of 2026. The bank puts its cumulative spending on the matter at over $100 million and says it has already handed over roughly 19 million documents. Ombudsman Neil Barofsky, however, accuses UBS of withholding materials — a charge the bank rejects.
The reputational drag from Washington arrives at a delicate moment. In Bern, lawmakers are weighing how much extra capital UBS should hold against its foreign subsidiaries — a debate that has kept the stock on edge for weeks. The Council of States' economics committee met last Tuesday to discuss potential capital buffers, and the broader chamber takes up the matter again on September 17. The original proposals from the Federal Council were tougher than what the committee is now exploring, and UBS said Tuesday it acknowledges the committee's efforts to weigh alternatives while voicing support for "targeted, internationally coordinated" adjustments to Swiss banking rules.
Should investors sell immediately? Or is it worth buying UBS?
Should the committee's initial recommendations be implemented in their original form, UBS calculates it would need to hold roughly $13 billion in additional Tier-1 capital at the parent level.
The Numbers Beneath the Noise
The buyback program rests on an operating performance that has given management little reason to flinch. Second-quarter net profit came in at $2.8 billion, bringing first-half earnings to $5.8 billion. Group assets under management reached $7.3 trillion. Pre-tax profit landed at $3.6 billion — or $3.9 billion on an underlying basis — with the return on CET1 capital hitting 15.4 percent and 16.4 percent respectively.
Reuters tallied the quarterly pre-tax figure as a 64 percent jump to $3.59 billion, powered largely by a booming equity trading desk. Core divisions collectively lifted underlying pre-tax profit by 47 percent year on year. Wealth management pulled in $36 billion in net new assets during the quarter, and $73 billion across the first half.
The integration math also continues to move in UBS's favor: since the acquisition closed in June 2022, the bank has banked $12.6 billion in cost savings and cut over 20,000 positions, according to Reuters.
Signals to Shareholders
The debt tender runs in parallel with a share repurchase program. UBS intends to spend at least $1 billion on its own stock over the next three months, building toward a total of $3 billion by mid-2027. The combination of trimming bond liabilities while buying back equity sends a clear confidence signal — even as the regulatory fight over future capital demands remains unresolved.
The market has taken notice. The stock trades at €47.19, roughly 2.1 percent below its 52-week high of €48.19, and sits 53 percent above its 52-week low of €30.87. Year to date, the shares have gained 19 percent. The resilience is notable given the dual headwinds: the Senate inquiry has yet to dent the share price, which sits just 1.6 percent under its July peak of €48.19 when quoted at €47.43.
UBS at a turning point? This analysis reveals what investors need to know now.
Management has also made quiet personnel moves. In January, Beatriz Martin Jimenez was named Group Chief Operating Officer, while Michelle Bereaux took on the role of Group Chief Compliance and Operational Risk Control Officer — both veterans of the Credit Suisse integration.
The bank's investment banking franchise, meanwhile, continues to win mandates that generate steady fees. UBS is acting as stabilization manager for a €600 million subordinated bond issued by Swiss Life Finance II AG and is among the banks involved in a Commerzbank AT1 offering — evidence that day-to-day business proceeds regardless of the noise.
Investors will get the next read on momentum when third-quarter results land on October 28. By then, the September 10 bond tender deadline will have passed, the Senate may have pressed further, and Bern's capital debate will have moved one step closer to a conclusion. For now, UBS is betting that its operational strength can outrun the political and legal clouds gathering on multiple fronts.
Ad
UBS Stock: New Analysis - 3 September
Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
